EXECUTIVE ENGAGEMENTS
OUTREACH
3788
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
682
Interactions with Platform & by Email
PARTICIPANTS
114
Unique # Participated
VALIDATIONS
51
Responses Validated*
COMPETITORS
29
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
207
PAGES
266
EDITION
16
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Brachytherapy estimated at US$330 Million in the year 2020, is projected to reach a revised size of US$413.7 Million by 2027, growing at aCAGR of 3.3% over the period 2020-2027. High Dose Rate, one of the segments analyzed in the report, is projected to record 3.5% CAGR and reach US$241.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Low Dose Rate segment is readjusted to a revised 2.9% CAGR for the next 7-year period.
The Brachytherapy market in the U.S. is estimated at US$89.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$85.8 Million by the year 2027 trailing a CAGR of 6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.9% and 2.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.
SELECT PLAYERS
Bard Medical Division; Best Medical International, Inc.; Best Vascular, Inc.; Boston Scientific Corporation; Carl Zeiss Meditec AG; Elekta AB; Sirtex Medical Limited; Sun Nuclear Corporation; Theragenics Corporation; Varian Medical Systems, Inc. ; Xoft, Inc.
SEGMENTS
» Type (High Dose Rate, Low Dose Rate) » Application (Prostate Cancer, Gynecological Cancer, Breast Cancer, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| Brachytherapy - A Prelude |
| Technological Advances to Boost Brachytherapy Uptake |
| Recent Market Activity |
| Growing Cancer Cases in Developing Countries Bode Well for the Brachytherapy Market |
| Cost Effectiveness - A Major Benefit of Brachytherapy |
| Competitive Landscape - An Overview |
| Key Market Statistics |
| The US Leads the Brachytherapy Devices Market Developing Regions to Spearhead Growth |
| Brachytherapy Provides More Hope for Cancer Patients, Compared to EBRT |
| Comparison of Brachytherapy Over EBRT in Prostate Cancer Treatment |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increase in Diagnosed Cases of Cancer - A Major Growth Driver |
| Cancer Prone Sites based on Age |
| Ballooning Global Population Offers Significant Growth Opportunities |
| Rising Healthcare Needs of Aging Global Population Drives Brachytherapy |
| Increasing Healthcare Spending in Emerging Markets |
| Scientific Evidence Continues to Support Brachytherapy in Prostate Cancer Treatment |
| Macular Degeneration - An Emerging Brachytherapy Application |
| APBI Therapy Rise in Popularity |
| IORT: Attractive Alternative to Traditional Radiation Treatment |
| Balloon Brachytherapy Gains Prominence |
| Growing Prominence of Imaging Techniques in Brachytherapy |
| Radiosensitizers - An Emerging Option to Improve Dose Delivery |
| Radiation Safety - An Important Issue in Brachytherapy Treatment |
| Residency Training on Brachytherapy - A Way to Improve Clinical Use |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Brachytherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for High Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for High Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for High Dose Rate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Low Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Low Dose Rate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Low Dose Rate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Gynecological Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Gynecological Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Gynecological Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Brachytherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Brachytherapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Brachytherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Brachytherapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Brachytherapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Brachytherapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Brachytherapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Brachytherapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Brachytherapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Brachytherapy by Type - High Dose Rate and Low Dose Rate - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Brachytherapy by Type - High Dose Rate and Low Dose Rate Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Brachytherapy by Type - Percentage Breakdown of Value Sales for High Dose Rate and Low Dose Rate for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Brachytherapy by Application - Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Brachytherapy by Application - Percentage Breakdown of Value Sales for Prostate Cancer, Gynecological Cancer, Breast Cancer and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 29 |
Focus On High Dose Rate, One of the Largest Segments in the Brachytherapy Market.
Will this Market be a Huge Opportunity by 2025?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com